Researchers Use Hybrid Quantum-Classical Workflow to Identify KRAS Inhibitors

figure chart

A multi-institution team of researchers led by Mohammad Ghazi Vakili (University of Toronto) and Christoph Gorgulla (St. Jude Children’s Research Hospital and Harvard University) reported using a hyrbid quantum-classical workflow to identify KRAS inhibitor drug candidates. KRAS is a well-known cancer causing gene.

The post Researchers Use Hybrid Quantum-Classical Workflow to Identify KRAS Inhibitors appeared first on HPCwire.

More Related Posts

What the future of work will mean for jobs, skills, and wages: Jobs lost, jobs gained | McKinsey

Jobs lost, jobs gained: What the future of work will mean for...

AI Factories and Creative GPU Utilization for AI

Businesses have embraced the use of artificial intelligence (AI), and most plan...

Next generation of moon rovers

CubeRover, engineered by Astrobotic’s Planetary Mobility department, was designed to offer an...

Home

Highly Niched Headhunters Specialized in Physical AI/Robotics, High-Performance Computing, Unmanned/Autonomous Systems, Defense Technology and Energy.

Specializations

We recruit across complex engineering markets where understanding the technology is critical to finding the right talent.

How We Work

Overview of how PACE partners with teams: Our process, what clients get, and why PACE is different.

About Us

PACE’s story, values, and culture define how we operate and who we are.

News & Insights

Stay up to date on industry trends.

Contact

All the information needed for anyone interested in contacting us.